ArticleProtoplasma2019
Transcriptomic analysis of Chinese wild Vitis pseudoreticulata in response to Plasmopara viticola.
Article in Protoplasma, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Unveiling the early defense response dynamics in grapevines against Plasmopara viticola by single-cell transcriptomics.Genome biology · 2026Article
- The Single-Stranded DNA-Binding GeneInternational journal of molecular sciences · 2022Article
- Integrated Analysis of Physiological, mRNA Sequencing, and miRNA Sequencing Data Reveals a Specific Mechanism for the Response to Continuous Cropping Obstacles inFrontiers in plant science · 2022Article
- Transcriptional profiling reveals multiple defense responses in downy mildew-resistant transgenic grapevine expressing a TIR-NBS-LRR gene located at the MrRUN1/MrRPV1 locus.Horticulture research · 2021Article
- Proteomic analysis of early-stage incompatible and compatible interactions between grapevine and P. viticola.Horticulture research · 2021Article
- Two-omics data revealed commonalities and differences between Rpv12- and Rpv3-mediated resistance in grapevine.Scientific reports · 2020Article
- Insight Into Function and Subcellular Localization ofFrontiers in microbiology · 2020Article
- The Nuclear-Localized RxLR Effector PvAvh74 FromFrontiers in microbiology · 2019Article
- Volatile 2-Phenylethanol and β-Cyclocitral Trigger Defense-Related Transcriptional and Metabolic Changes in Grapevine Leaves Against Downy Mildew.Physiologia plantarumArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Downy mildew, resulted from Plasmopara viticola, is one of most severe fungal diseases of grapevine. Since Vitis vinifera is susceptible to downy mildew, much effort has been focused on improving the resistance of V. vinifera. The Chinese wild V. pseudoreticulata accession Baihe-35-1 (BH) shows resistance to P. viticola; however, the molecular mechanism underlying its resistance to P. viticola is largely unknown. In order to better understand the cellular processes, the transcriptomic changes were investigated at 0, 12, 24, 48, 96, and 120 h post infection (hpi). Transcriptome analysis identified a total of 175 differentially expressed genes. Most of them were found to be associated with oxidative stress, cell wall modification, and protein modification. Moreover, the BH resistance to P. viticola was involved in metabolism process, including terpene synthesis and hormone synthesis. In addition, we verified 12 genes to ensure the accuracy of transcriptome data using quantitative real-time PCR (qRT-PCR). This study broadly characterizes a molecular mechanism in which oxidative stress and cell wall biosynthesis and modification play important roles in the response of BH to P. viticola and provides a basis for further analysis of key genes involved in the resistance to P. viticola.
Indexed as
Identifiers
31115695What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.